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Abstract
Objective:  To  verify  the  presence  of  anti-rotavirus  serotype  G9P[5]  SIgA  and  the  virus  neutral-
ization capacity  of  milk  samples  from  Brazilian  women.
Methods:  SIgA  antibody  levels  reactive  to  rotavirus  G9  were  determined  in  30  maternal  milk
samples by  enzyme-linked  immunosorbent  assay  (ELISA)  using  puriﬁed  virus  suspensions.  The
samples’  capacity  to  neutralize  rotavirus  G9P[5]  was  analyzed  using  the  MA-104  cells  neutral-
ization  assay.
Results:  Great  individual  variations  were  observed  regarding  the  SIgA  levels  and  neutralization
titers, but  all  samples  showed  some  G9P[5]  neutralizing  ability.  A  highly  signiﬁcant  positive
correlation  was  observed  between  antibody  levels  and  neutralization  titers.
Conclusions: The  high  correlation  between  anti-rotavirus  antibody  levels  and  neutralizing
capacity of  the  milk  samples  suggests  a  possible  protective  role  of  these  antibodies  against
infection. These  results  also  support  the  encouragement  of  the  breast-feeding  practice.
©  2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Leite  de  mulheres  brasileiras  apresenta  anticorpos  IgA  secretores  (SIgA)  que
neutralizam  o  rotavírus  G9P[5]
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Objetivo:  Veriﬁcar  a  presenc¸a de  SIgA  anti-rotavírus  sorotipo  G9P[5]  e  a  capacidade  de
neutralizac¸ão do  vírus  de  amostras  de  leite  de  mulheres  brasileiras.
Métodos:  Foram  determinados  os  níveis  de  anticorpos  IgAS  reativos  contra  rotavírus  G9  em
30 amostras  de  leite  materno  por  ELISA  usando  suspensões  puriﬁcadas  do  vírus.  A  capacidade
das  amostras  de  neutralizarem  o  rotavírus  G9P[5]  foi  analisada  em  ensaio  de  neutralizac¸ão
utilizando células  MA-104.
 Please cite this article as: Santos SM, Ferreira TL, Quintal VS, Carbonare SB, Tino-De-Franco M. Milk from Brazilian women presents
ecretory IgA antibodies and neutralizes rotavirus G9P[5]. J Pediatr (Rio J). 2013;89:510--3.
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Resultados:  Foram  observadas  grandes  variac¸ões  individuais  referentes  aos  níveis  de  IgAS  e
títulos de  neutralizac¸ão,  mas  todas  as  amostras  mostraram  certa  capacidade  de  neutralizar  o
G9P[5].  Veriﬁcamos  uma  correlac¸ão  positiva  altamente  signiﬁcativa  entre  os  níveis  de  anticorpos
e  os  títulos  de  neutralizac¸ão.
Conclusões: A  alta  correlac¸ão  entre  níveis  de  anticorpos  anti-rotavírus  e  a  capacidade  neu-
tralizante das  amostras  de  leite  sugere  um  possível  papel  protetor  desses  anticorpos  contra  a
infecc¸ão.  Esses  resultados  também  apoiam  o  incentivo  à  prática  do  aleitamento  materno.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
n
g
d
s
o
u
I
E
o
c
h
t
n
t
p
i
a
c
o
p
t
d
l
d
T
a
n
v
c
A
t
m
t
6
e
S
w
t
R
Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Rotaviruses  are  among  the  major  causes  of  gastroenteri-
tis affecting  young  children  worldwide.1 The  causative
rotavirus agent  has  a  capsid  structure  with  two  protein
layers. The  outer  capsid  is  composed  of  two  structural  pro-
teins that  determine  the  rotavirus  serotype  classiﬁcation:
VP7 (glycoprotein,  G  types)  and  VP4  (protease-sensitive,  P
types); both  induce  neutralizing  and  protective  antibodies.
The inner  capsid  contains  the  structural  protein  VP6,  which
determines the  rotavirus  serogroup.2 The  G9  serotype  is
frequently detected  in  humans,  and  was  the  second  most
frequent G  type  among  rotavirus  diseases  and  strains  cir-
culating in  Latin  America  and  the  Caribbean  from  1990  to
2009.3 High  occurrences  of  the  G9  strain  have  been  detected
in Brazil  since  1998.4,5
Children  have  an  immature  immune  system,  and  they
depend on  the  antibodies  that  they  receive  from  their
mothers through  the  placenta  during  pregnancy  or  from
the colostrum  and  breast  milk  after  birth  to  protect  them
against infections.6 However,  there  is  no  current  consensus
regarding the  role  of  maternal  antibodies  against  rotavirus
infections. Some  studies  have  reported  lower  infection  rates
among infants  that  have  been  exclusively  breast-fed,  when
compared to  non-breast-fed  infants,7,8 while  other  studies
have failed  to  detect  any  protective  effect  of  breast-
feeding.9,10
Other  reports  investigating  anti-rotavirus  antibodies  in
human milk  have  suggested  that  they  may  interfere  with
anti-rotavirus vaccine  efﬁciency  by  neutralizing  the  virus
particles present  in  the  vaccine  before  they  can  multiply
within the  intestinal  cells,  thus  diminishing  the  immunolog-
ical potential  of  the  vaccine.11,12
A  pentavalent  human-bovine  rotavirus  vaccine  contain-
ing the  serotypes  G1,  G2,  G3,  G4,  and  G9  is  currently  under
development at  the  Butantan  Institute  (Brazil)  for  human
use. The  aim  of  this  study  was  to  investigate  the  presence
of SIgA  antibodies  reactive  to  the  rotavirus  serotype  G9P[5]
in milk  samples  from  Brazilian  mothers  and  their  capacity  to
neutralize virus  particles,  since  it  may  affect  the  immuniza-
tion efﬁciency  of  vaccines  containing  the  G9  serotype.
MethodsThe  presence  of  SIgA  anti-rotavirus  serotype  G9P[5]  (human
vaccine strain)  was  analyzed  by  enzyme-linked  immunosor-
bent assay  (ELISA)  in  30  milk  samples  collected  from  healthy
S
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wursing  mothers,  aged  between  19  and  38  years,  who  had
iven birth  at  the  Hospital  Universitário  da  Universidade
e São  Paulo,  which  mostly  attends  to  patients  from  lower
ocio-economic levels,  a group  that  is  highly  representative
f the  Brazilian  female  population.  All  samples  were  man-
ally collected  in  the  morning,  between  breast-feedings.
nformed consent  from  the  patients  and  approval  from  the
thics Committee  of  the  Universidade  de  São  Paulo  were
btained prior  to  the  collections.  The  milk  samples  were
ollected from  nursing  mothers  with  good  nutritional  and
ealth condition,  who  were  not  receiving  any  medications
hat might  have  interfered  with  the  lactation,  and  had
egative serology  for  HIV,  hepatitis  B,  and  syphilis.  ELISA
ests were  performed  by  coating  half  of  the  microtiter
lates with  5  g/mL  of  viral  antigen  (supernatant  of  MA-104-
nfected culture  cells  that  had  been  ultracentrifuged  onto
 30%  sucrose  cushion)  and  the  other  half  with  the  same
oncentration of  control  antigen  solution  (the  supernatant
f ultracentrifuged  non-infected  cells).  A  milk  pool  was  pre-
ared from  equal  volumes  of  50  different  milk  samples  from
he Milk  Bank  of  the  Hospital  Universitário  da  Universidade
e São  Paulo  and  used  as  a  positive  control.  The  antibody
evels were  calculated  by  the  difference  between  the  optical
ensity readings  obtained  with  viral  and  control  antigens.
he ﬁnal  titers  were  reported  as  relative  titers,  in  percent-
ges, considering  the  milk  pool  as  100%.
The  milk  samples  were  also  tested  for  their  G9P[5]-
eutralizing ability  using  MA-104  cell  cultures.  Equal
olumes of  milk  sample  serial  dilutions  and  a suspension
ontaining 100  TCID50/mL  of  G9P[5]  rotavirus  were  mixed.
fter 30  minutes  of  incubation,  the  mixtures  were  added
o a  conﬂuent  monolayer  of  MA-104  cells  grown  in  96-well
icroplates. Neutralizing  antibody  titers  were  considered  as
he highest  dilution  of  the  samples  that  showed  more  than
0% cytopathic  effect  inhibition  after  48  hours  of  incubation.
The  correlations  between  the  milk  samples  SIgA  lev-
ls and  the  neutralization  titers  were  calculated  using  the
pearman correlation  coefﬁcient.  The  conﬁdence  interval
as set  at  95%  (95%  CI)  and  p-values  <  0.05  were  considered
o be  statistically  signiﬁcant.
esultsIgA  anti-rotavirus  and  neutralization  titers,  with  maximum
nd minimum  values,  75th and  25th percentiles,  mean,  and
edian are  presented  in  Fig.  1.  Great  individual  variations
ere observed  within  the  SIgA  titers  obtained  by  ELISA.  The
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Figure  1  Anti-rotavirus  SIgA  antibodies  and  neutralizing  titers
in milk  samples.
Box plots:  []  -  medians;  []  -  means;  []  -  discrepant  values;
bottom edge  of  the  box:  25th percentile;  top  edge  of  the  box  -
75th percentile;  bottom  short  line  -  lowest  value;  top  short  line
- highest  value.
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pigure  2  Correlations  between  neutralizing  and  anti-
otavirus SIgA  titers  in  milk  samples  (r  =  0.740;  p  <  0.0001).
eutralization  titers  determined  by  the  neutralization  assay
lso varied  widely.  The  highest  titer  obtained  (160)  was  16
imes greater  than  the  lowest  titer  (10),  and  one  sample
howed a  discrepant  value.
Fig.  2  shows  the  correlation  between  SIgA  and  neu-
ralization titers.  One  sample  showed  very  high  IgA  and
eutralization titers  discrepant  from  the  others.  A  high
igniﬁcant and  positive  Spearman  correlation  coefﬁcient
r =  0.740,  p  <  0.0001)  was  observed  in  the  statistical  analysis
omparing the  two  parameters.
iscussion
he  levels  of  protection  induced  by  currently  available
nti-rotavirus vaccines  appear  to  vary  depending  on  the
ocality where  they  have  been  administered.  The  protection
onferred by  vaccination  diminished  signiﬁcantly  in  many
ountries in  Africa  and  Asia  compared  to  more  developed
ations, such  as  Finland.13 However,  the  factors  that  inﬂu-
nce the  low  immunogenicity  of  these  vaccines  are  not  yet
lear. One  possible  explanation  could  be  the  presence  of
nti-rotavirus antibodies  in  the  milk  of  nursing  mothers  in
eveloping countries  where  breast-feeding  is  a  more  com-
on practice.  Due  the  presence  of  these  antibodies,  if  the
nfants are  nursed  within  short  periods  of  time  either  before
RSantos  SM  et  al.
r  after  oral  vaccination,  the  immunological  beneﬁts  could
e compromised.11,12 Thus,  it  becomes  important  to  study
he anti-rotavirus  antibody  repertoire  present  in  the  breast
ilk that  may  potentially  interfere  with  the  immunogenicity
nd efﬁcacy  of  the  vaccine  that  is  currently  under  develop-
ent in  Brazil.
Even though  the  circulation  of  the  G9  serotype  is  vari-
ble in  developing  countries  (depending  on  the  time  of  year
nd the  locality),  this  serotype  has  been  found  to  be  quite
revalent in  Brazil  since  1998.4,5 As  such,  the  Brazilian  popu-
ation has  been  widely  exposed  to  this  serotype,  which  could
nﬂuence the  repertoire  of  antibodies  present  in  the  milk  of
ursing mothers.  This  repertoire  is  a  result  of  the  humoral
mmune response  to  antigens  to  which  they  were  exposed.
he large  variations  in  the  levels  of  anti-rotavirus  SIgA  anti-
odies that  have  been  observed  in  these  women  may  reﬂect
he different  degrees  of  their  exposition  to  the  G9  serotype.
The  capacity  of  maternal  milk  to  neutralize  the  G9P[5]
erotype was  also  evaluated.  All  samples  showed  some
bility to  neutralize  the  virus,  with  a  broad  variation  in  neu-
ralization titers.  The  positive  correlation  observed  between
he SIgA  anti-rotavirus  and  neutralization  titers  suggest  that
nti-rotavirus G9  antibodies  play  a  role  in  virus  neutraliza-
ion.
However, the  fact  that  some  samples  showed  high  SIgA
iters (≥  80)  and  low  neutralization  titers  (<  5),  while  other
resented high  neutralization  titers  but  low  SIgA  titers,
annot be  ignored.  As  such,  the  possibility  that  other  com-
onents of  the  mothers’  milk  are  also  important  in  viral
eutralization must  be  considered.  For  instance,  lactadherin
as been  observed  to  inhibit  rotavirus  infection  in  vitro.14
The  presence  of  SIgA  anti-rotavirus  G9  in  mothers’  milk
hould not  be,  by  any  means,  considered  an  argument
gainst nursing.  To  the  contrary,  the  antibodies  present  in
aternal milk  can  potentially  protect  nursing  infants  against
otavirus infections  in  early  age,  and  for  this  reason  the
ractice should  be  encouraged,  particularly  in  developing
ountries. Additionally,  aiming  to  improve  the  effectiveness
f immunizations,  an  interval  between  breastfeeding  and
accination should  be  advised.
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